Prolor Biotech, Human Growth Hormone, HGH Injections

Prolor Biotech

Prolor Biotech

advanced 4.2% on the stock market. The company was cleared by the U.S. Food and Drug Administration to conduct a Phase II clinical trial in the U.S. of its longer-acting version of human growth hormone, hGH-CTP.

Prolor Biotech is an Israel based bio tech company and developer of trial human growth hormone. Human growth hormone is the latest anti aging drug that has been known to

• Diminished wrinkles, crow’s feet, laugh lines, and age spots
• Skin that looks and feels firmer and smoother
• Increased physical stamina
• Weight loss with decreased body fat
• Increased lean muscle
• Strengthened nails
• Restored hair condition and color
• A faster metabolism
• Stronger bones and increased bone density
• Greater memory and focus
• Reinvigorated sex drive and performance
• Better mood and mental sharpness
• Lowered cholesterol
• Better sleep
• Clearer, healthier vision
• A strengthened immune system
• Increased results from exercise

The race is on for which company can produce FDA approved daily injections of HGH which has the potential to dominate a $25 billion market. For years many high level athletes have been taking HGH to increase their sports performance which has translated in increasing stamina and muscle mass. The sports of cycling and most recently the baseball scandals have put HGH into the news headlines.

Now many companies are trying to get FDA approved for a HGH injection for everyday people.

Prolor Biotech has just entered Phase II in the application process for HGH which is designed to dramatically reduce the number of interventions required to achieve the same therapeutic effect from the same dosage and reduce the number of injections needed from a daily schedule to weekly.

Prolor Biotech is trying to gain extended patent protection as proprietary new formulations of existing therapies to achieve faster commercialization with lower risks and costs than those typically associated with a new therapeutic protein; and PROLOR Biotech is currently developing long-lasting versions for the following existing therapeutic proteins and peptides:

• MOD-4023: hGH-CTP – $2.7 billion current market, no available long-lasting therapeutics
• MOD-9023: IFN-ß-CTP – $4.7 billion current market, no available long-lasting therapeutics
• MOD-5023: Factor VIIa-CTP – $1.2 billion current market, no available long-lasting therapeutics
• MOD-7023: EPO-CTP – $10 billion current market, available long-lasting therapeutics
• MOD-1001: GLP-1-CTP – $1.0 billion estimated potential market, no available long-lasting therapeutics
• MOD-1002: OBES-CTP – $5.0 billion estimated potential market, no available long-lasting therapeutics

Though Prolor Biotech is in the latest development of HGH if and when it does get approved it can only be prescribed by a doctor.

There are herbal HGH supplements that can be bought that are called HGH releasers. These HGH boosters are made with natural herbal supplements that when taken stimulate the body to produce more HGH into the body.

It may take years for Prolor Biotech to get FDA approval and even than you would need a doctor’s prescription.

To review the top HGH products check out our review section. http://www.hgharticles.com/top-hgh-products/

Buy HGH

Tags: FDA, HGH injection, HGH supplements, Prolor Biotech